Have £2k to invest? Why I think Aviva could be the best place to invest

Aviva plc (LON: AV) shares look too cheap to pass up.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Plenty of companies in the FTSE 100 look unloved right now, with Aviva (LSE: AV) up there as one of the most hated. Year-to-date shares in this financial services giant have collapsed by nearly 25%, excluding dividends, underperforming the FTSE 100 by around 14%. 

Following this decline, Aviva’s dividend yield has spiked to 8.7%, putting the company in the top 10 highest yielding stocks in the FTSE 100 (it’s number eight). If you have some money to invest, I think it’s worth taking advantage of the opportunity. Here’s why. 

Oversold 

Before I get into what I like about Aviva, I want to take a look at the reasons behind the stock’s decline over the past few weeks. 

It seems as if there are three main reasons why investors have deserted the firm. Firstly, Brexit uncertainty, which is weighing on all FTSE stocks not just Aviva’s, and the company can’t do much about this.

Second, CEO Mark Wilson, who has steered the business since 2013, recently announced that he’s stepping down. Analysts were somewhat surprised by this announcement as Wilson has done a fantastic job of turning Aviva around and re-building the business after the financial crisis.

And lastly, Aviva has been hit by Government plans to tighten regulation of the equity release lifetime mortgages (LTM) market, in which Aviva is the largest player. 

On this last point, a few days ago the Prudential Regulation Authority (PRA) published more information on the proposed changes for LTM providers. The guidance was less demanding than first feared, which is good news for Aviva. 

Management changes

So, changes to LTM regulation might not be as bad as feared, and the company can’t do much about Brexit, but should we be worried about Wilson’s departure? 

I think his decision to step down is a signal to the market he believes his job is done. Aviva is in a much better position than when he took over.

The company has plenty of excess capital, which it’s using to pay down expensive debt, buy back shares, and is planning to spend some of these funds on acquisitions to help reinforce its position in the insurance market. Put simply, I don’t think Wilson’s decision to step down is a red flag for investors. 

Time to buy? 

After considering all of the above, I’m of the decision that shares in Aviva are a good deal today. Not only does the stock support a dividend yield of 8.7%, but it’s also changing hands at a highly attractive valuation of just 6.7 times forward earnings. 

In my view, this multiple is too cheap to pass up. The rest of the insurance industry is trading at an average P/E of 10, indicating that Aviva is undervalued by around 49%. This potential for capital gains, plus the dividend yield of 8.7%, leads me to conclude that Aviva could be a great addition to any portfolio. 

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Dominos delivery man on skateboard holding pizza boxes
Investing Articles

£5,000 invested in high-yield FTSE 250 stock Domino’s Pizza on 7 April is now worth…

Anyone who put £5,000 into FTSE stock Domino’s Pizza after the Easter break would now be laughing as its share…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

Tesla stock’s up 50% in a year. Could it go even higher?

This week saw Tesla announce mixed first-quarter results. Yet Tesla stock's worth half as much again as a year ago.…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

Up 9% today, is this FTSE 250 share’s recovery gaining pace?

This FTSE 250 share has had a welcome boost in the market today after it unveiled an upbeat trading statement.…

Read more »

Lady wearing a head scarf looks over pages on company financials
Investing Articles

5 years ago Barclays shares cost just 181p! Are they still a buy at today’s 434p?

Harvey Jones says investors have to pay a lot more to buy Barclays shares than just a few years ago,…

Read more »

Tanker coming in to dock in calm waters and a clear sunset
Investing Articles

Up 36%, could Shell shares still offer value for the long term?

Christopher Ruane has owned Shell shares before -- and got burnt by a dividend cut. Could recent oil price rises…

Read more »

A young Asian woman holding up her index finger
Investing Articles

£5,000 invested in FTSE 100 stock London Stock Exchange Group 1 month ago is now worth…

FTSE 100 powerhouse London Stock Exchange Group has been dragged into the software sell-off. However, recently, it has started to…

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

The Barratt Redrow share price trades at a 13-year low! Is it a screaming buy at 266p?

The Barratt Redrow share price has taken a battering in recent years but Harvey Jones says the FTSE 100 stock…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Growth Shares

Why is everyone buying Rio Tinto shares?

Rio Tinto shares are the flavour of the week among investors. Paul Summers is asking whether this momentum will continue.

Read more »